Boundless Bio Inc.
BOLD | NASDAQ
$2.87
+$0.04 (+1.41%)
Sep 22, 2026, 2:08 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 |
|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.25M | 1.09M | n/a | n/a | n/a |
Gross Profit | -1.25M | -1.09M | n/a | n/a | n/a |
Operating Income | -63.55M | -73.27M | -54.8M | -46.47M | -25.3M |
Interest Income | 5.36M | 7.89M | 5.28M | 668K | 96K |
Pretax Income | -58.2M | -65.36M | -49.43M | -45.9M | -25.21M |
Net Income | -58.2M | -65.36M | -49.43M | -45.9M | -25.21M |
Selling & General & Admin | 18.71M | 18M | 12.16M | 9.31M | 6.02M |
Research & Development | 44.85M | 55.27M | 42.64M | 37.16M | 19.28M |
Other Expenses | -1.25M | -1.09M | n/a | n/a | n/a |
Operating Expenses | 62.3M | 72.18M | 54.8M | 46.47M | 25.3M |
Interest Expense | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 63.55M | 73.27M | 54.8M | 46.47M | 25.3M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 22.36M | 16.98M | 22.24M | 22.24M | 22.24M |
Shares Outstanding (Diluted) | 22.36M | 16.98M | 22.24M | 22.24M | 22.24M |
EPS (Basic) | -2.60 | -3.85 | -2.22 | -2.06 | -1.13 |
EPS (Diluted) | -2.60 | -3.85 | -2.22 | -2.06 | -1.13 |
EBITDA | -56.95M | -64.28M | -48.48M | -44.96M | -24.53M |
EBIT | -58.2M | -65.36M | -49.43M | -45.9M | -25.21M |
Depreciation & Amortization | 1.25M | 1.09M | 957K | 942K | 682K |
Add to Watchlist
Select watchlists to add or remove BOLD